Presentation Information

[P043]Cross-serotype Neutralization and Enhancement Profiles of Acute-Phase Antibodies during the 2017 DENV-2 Outbreak in Sri Lanka.

○Ngan Thi Thanh Nguyen1, Rohita Muthugala2, Kouichi Morita1,3, Mya Myat Ngwe Tun1,3,4,5 (1. Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University (Japan), 2. Department of Molecular Biology, Medical Research Institute, Colombo 08, Sri Lanka (Sri Lanka), 3. Department of Virology, Institute of Tropical Medicine (Nekken-Virology), Nagasaki University, Sakamoto 1-12-4, Nagasaki 852-8523, Japan. (Japan), 4. Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases Shimane University, Izumo, Japan (Japan), 5. DEJIMA Infectious Disease Research Alliance, Nagasaki University, Nagasaki, Japan (Japan))

Password required to view


Comment

To browse or post comments, you must log in.Log in